1. Home
  2. TRAW vs FBGL Comparison

TRAW vs FBGL Comparison

Compare TRAW & FBGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRAW
  • FBGL
  • Stock Information
  • Founded
  • TRAW 1998
  • FBGL 1996
  • Country
  • TRAW United States
  • FBGL Singapore
  • Employees
  • TRAW N/A
  • FBGL N/A
  • Industry
  • TRAW
  • FBGL Miscellaneous manufacturing industries
  • Sector
  • TRAW
  • FBGL Consumer Discretionary
  • Exchange
  • TRAW NYSE
  • FBGL Nasdaq
  • Market Cap
  • TRAW 7.8M
  • FBGL 7.8M
  • IPO Year
  • TRAW 2013
  • FBGL 2025
  • Fundamental
  • Price
  • TRAW $1.65
  • FBGL $0.66
  • Analyst Decision
  • TRAW
  • FBGL
  • Analyst Count
  • TRAW 0
  • FBGL 0
  • Target Price
  • TRAW N/A
  • FBGL N/A
  • AVG Volume (30 Days)
  • TRAW 3.5M
  • FBGL 143.2K
  • Earning Date
  • TRAW 05-15-2025
  • FBGL 01-01-0001
  • Dividend Yield
  • TRAW N/A
  • FBGL N/A
  • EPS Growth
  • TRAW N/A
  • FBGL N/A
  • EPS
  • TRAW N/A
  • FBGL N/A
  • Revenue
  • TRAW $227,000.00
  • FBGL $10,146,582.00
  • Revenue This Year
  • TRAW $3.81
  • FBGL N/A
  • Revenue Next Year
  • TRAW $30.43
  • FBGL N/A
  • P/E Ratio
  • TRAW N/A
  • FBGL N/A
  • Revenue Growth
  • TRAW 0.44
  • FBGL N/A
  • 52 Week Low
  • TRAW $0.97
  • FBGL $0.44
  • 52 Week High
  • TRAW $19.44
  • FBGL $5.45
  • Technical
  • Relative Strength Index (RSI)
  • TRAW 54.15
  • FBGL N/A
  • Support Level
  • TRAW $1.30
  • FBGL N/A
  • Resistance Level
  • TRAW $2.58
  • FBGL N/A
  • Average True Range (ATR)
  • TRAW 0.23
  • FBGL 0.00
  • MACD
  • TRAW 0.07
  • FBGL 0.00
  • Stochastic Oscillator
  • TRAW 34.04
  • FBGL 0.00

About TRAW TRAWS PHARMA INC

Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.

About FBGL FBS Global Limited Ordinary Shares

FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial, and industrial building projects. As a green contractor focused on environmentally sound practices, the company aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply and installation of ceilings, partitions, timber deck, carpet, acoustic wall paneling, built-in furniture as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts and Sales of construction materials.

Share on Social Networks: